Feed MIRM
MI
Mirum Pharmaceuticals, Inc.
MIRM · NASDAQ
$98.70 -1.58% (-$1.58)
1M -17.09%
Market Cap $6.0B
P/E Ratio -
Div. Yield -
ROE 289.33%
Bulios Fair Price
$76.74
22.2% downside
Preț actual
$98.7
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile MIRM sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Valuation
0 /100
Expensive P/S 10.57x
P/B 24.82x
P/E N/A
Growth
100 /100
Growing Rev. growth 89.13%
Book val. growth 30.36%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 94.06%
Net margin 140.24%
Op. margin 12.31%
Quality
8 /100
Poor ROIC 11.32%
ROE 289.33%
ROA 89.67%
Debt
42 /100
Moderate Debt/Equity 1.34x
Current ratio 2.09x
Int. coverage -30.75x
Stability
34 /100
Moderate Beta 0.49x
Rev. volatility 44.71%
EPS volatility 38.21%
Întreabă StockBot despre MIRM
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christopher Peetz
Employees
372
Headquarters
Foster City
Evenimente viitoare
03 NOV.
Earnings
Upcoming earnings report